Analystreport

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) is now covered by analysts at UBS Group AG. They set a "buy" rating on the stock.

Sarepta Therapeutics, Inc.  (SRPT) 
Last sarepta therapeutics, inc. earnings: 2/26 04:05 pm Check Earnings Report